Skip to main content

Table 2 Comparison of echocardiography findings between patients with rheumatoid arthritis (RA) and control subjects

From: Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis

Variables

RA patients (n=61)

Controls (n=107)

P value

LVEDD, mm

46 (44.3–49.3)

45.0 (42.6–47.0)

0.033

LVESD, mm

29.1 (27.2–31.4)

28.1 (26.0–30.0)

0.131

LV mass index, g/m2

151.7 (128.2–173.1)

140 (119–165)

0.043

LV ejection fraction, %

64 (61.7–65.8)

64.6 (62.0–67.3)

0.349

LV filling pressure, E/Em

9.4 (8.5–10.1)

9.0 (8.7–10.0)

0.036

Transmitral E wave velocity, cm/s

68.5 (55.3–79.9)

72.4 (64.0–82.8)

0.008

Transmitral A wave velocity, cm/s

70.0 (57.0–81.8)

65.8 (57.0–77.0)

0.045

Transmitral E wave / A wave verocity

0.93 (0.77–1.28)

1.15 (0.85–1.32)

0.003

Systolic tissue velocity (Sm), cm/s

6.9 (6.1–8.0)

8.0 (7.0–9.0)

<0.001

Early diastolic tissue velocity (Em), cm/s

7.7 (6.0–10.4)

9.8 (7.4–11.9)

0.001

Late diastolic tissue velocity (Am), cm/s

8.7 (7.2–9.6)

9.3 (8.0–10.5)

0.105

Transmitral E wave deceleration time, ms

201 (175.7–227.3)

190.4 (163.7–214.8)

0.047

  1. Data are presented as median (IQR). LVEDD, left ventricular end diastolic dysfunction; LVESD, left ventricular end systolic dysfunction; E, transmitral E wave velocity; A, transmitral A wave velocity; Sm, systolic tissue velocity; Em, early diastolic tissue velocity; Am, late diastolic tissue velocity; DT, transmitral E wave deceleration time